Table 12.
GHK and Genes Associated with Neurons.
| UP | Gene Title | Percent Change |
| 1 | opioid receptor, mu 1, OPRM1 | 1294 |
| 2 | tumor protein p73, TP73 | 938 |
| 3 | potassium voltage-gated channel, Shal-related subfamily, member 1, KCND1 | 845 |
| 4 | solute carrier family 8 (sodium/calcium exchanger), member 2, SLC8A2 | 737 |
| 5 | contactin associated protein-like 2, CNTNAP2 | 581 |
| 6 | stathmin-like 3, STMN3 | 500 |
| 7 | latrophilin 3, LPHN3 | 494 |
| 8 | angiopoietin 1, ANGPT1 | 487 |
| 9 | synapsin III, SYN3 | 478 |
| 10 | dipeptidyl-peptidase 6, DPP6 | 448 |
| 11 | somatostatin receptor 2, SSTR2 | 442 |
| 12 | G protein-coupled receptor, family C, group 5, member B, GPRC5B | 431 |
| 13 | sodium channel, voltage-gated, type III, alpha subunit, SCN3A | 423 |
| 14 | smoothened homolog (Drosophila), SMO | 415 |
| 15 | tryptophan hydroxylase 1, TPH1 | 409 |
| 16 | caspase 8, apoptosis-related cysteine peptidase, CASP8 | 399 |
| 17 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 /// gamma-aminobutyric acid receptor subunit alpha-5-like, GABRA5 /// LOC100509612 | 392 |
| 18 | transcription factor 7 (T-cell specific, HMG-box), TCF7 | 372 |
| 19 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, SLC17A6 | 369 |
| 20 | doublecortin-like kinase 1, DCLK1 | 365 |
| 21 | p21 protein (Cdc42/Rac)-activated kinase 1, PAK1 | 363 |
| 22 | neurogenic differentiation 4, NEUROD4 | 362 |
| 23 | zinc finger protein 335, ZNF335 | 358 |
| 24 | wingless-type MMTV integration site family, member 3, WNT3 | 352 |
| 25 | ADAM metallopeptidase domain 8, ADAM8 | 352 |
| 26 | neuropeptide Y, NPY | 346 |
| 27 | potassium voltage-gated channel, Shaw-related subfamily, member 3, KCNC3 | 332 |
| 28 | EPH receptor B1, EPHB1 | 330 |
| 29 | LIM domain kinase 1, LIMK1 | 322 |
| 30 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila), MLL | 318 |
| 31 | growth associated protein 43, GAP43 | 305 |
| 32 | FBJ murine osteosarcoma viral oncogene homolog, FOS | 305 |
| 33 | sal-like 1 (Drosophila), SALL1 | 302 |
| 34 | synovial sarcoma, X breakpoint 2 /// synovial sarcoma, X breakpoint 2B, SSX2 /// SSX2B | 301 |
| 35 | inositol 1,4,5-triphosphate receptor, type 3, ITPR3 | 298 |
| 36 | bone morphogenetic protein receptor, type IB, BMPR1B | 298 |
| 37 | synuclein, gamma (breast cancer-specific protein 1), SNCG | 292 |
| 38 | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit, CACNA1A | 286 |
| 39 | capping protein (actin filament) muscle Z-line, beta, CAPZB | 285 |
| 40 | plexin C1, PLXNC1 | 282 |
| 41 | nuclear factor I/B, NFIB | 279 |
| 42 | islet amyloid polypeptide, IAPP | 276 |
| 43 | nephroblastoma overexpressed gene, NOV | 275 |
| 44 | hyperpolarization activated cyclic nucleotide-gated potassium channel 4, HCN4 | 269 |
| 45 | calsyntenin 2, CLSTN2 | 268 |
| 46 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, KCNN1 | 266 |
| 47 | sodium channel, voltage-gated, type II, alpha subunit, SCN2A | 264 |
| 48 | neuroligin 1, NLGN1 | 261 |
| 49 | ELKS/RAB6-interacting/CAST family member 2, ERC2 | 261 |
| 50 | scratch homolog 1, zinc finger protein (Drosophila), SCRT1 | 252 |
| 51 | low density lipoprotein receptor-related protein 1, LRP1 | 249 |
| 52 | hypothetical protein LOC728392 /// NLR family, pyrin domain containing 1, LOC728392 /// NLRP1 | 249 |
| 53 | opiate receptor-like 1, OPRL1 | 246 |
| 54 | myosin, heavy chain 14, non-muscle, MYH14 | 243 |
| 55 | nitric oxide synthase 1 (neuronal), NOS1 | 240 |
| 56 | wingless-type MMTV integration site family, member 2B, WNT2B | 238 |
| 57 | glutamate receptor, metabotropic 1, GRM1 | 231 |
| 58 | glutamate receptor interacting protein 1, GRIP1 | 230 |
| 59 | myelin associated glycoprotein, MAG | 229 |
| 60 | chemokine (C-C motif) ligand 3 /// chemokine (C-C motif) ligand 3-like 1 /// chemokine (C-C motif) ligand 3-like 3, CCL3 /// CCL3L1 /// CCL3L3 | 228 |
| 61 | family with sequence similarity 162, member A, FAM162A | 228 |
| 62 | sphingosine-1-phosphate receptor 5, S1PR5 | 227 |
| 63 | protein tyrosine phosphatase, receptor type, R, PTPRR | 225 |
| 64 | IKAROS family zinc finger 1 (Ikaros), IKZF1 | 225 |
| 65 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, KCNN3 | 221 |
| 66 | solute carrier family 18 (vesicular monoamine), member 2, SLC18A2 | 219 |
| 67 | glutamate receptor, ionotropic, N-methyl d-aspartate 1, GRIN1 | 216 |
| 68 | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian), SRC | 216 |
| 69 | jagged 1, JAG1 | 215 |
| 70 | adenylate cyclase activating polypeptide 1 (pituitary), ADCYAP1 | 215 |
| 71 | ATPase, Ca++ transporting, plasma membrane 2, ATP2B2 | 214 |
| 72 | tripartite motif-containing 2, TRIM2 | 213 |
| 73 | netrin 1, NTN1 | 212 |
| 74 | paired related homeobox 1, PRRX1 | 209 |
| 75 | purinergic receptor P2X, ligand-gated ion channel, 3, P2RX3 | 207 |
| 76 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein, ID4 | 203 |
| 77 | solute carrier family 5 (choline transporter), member 7, SLC5A7 | 202 |
| 78 | empty spiracles homeobox 1, EMX1 | 202 |
| 79 | muscle, skeletal, receptor tyrosine kinase, MUSK | 200 |
| 80 | GATA binding protein 2, GATA2 | 193 |
| 81 | cadherin 13, H-cadherin (heart), CDH13 | 192 |
| 82 | Rho/Rac guanine nucleotide exchange factor (GEF) 2, ARHGEF2 | 191 |
| 83 | anaplastic lymphoma receptor tyrosine kinase, ALK | 191 |
| 84 | cholecystokinin A receptor, CCKAR | 190 |
| 85 | GLI family zinc finger 2, GLI2 | 183 |
| 86 | cholinergic receptor, nicotinic, beta 1 (muscle), CHRNB1 | 182 |
| 87 | NK2 homeobox 2, NKX2-2 | 181 |
| 88 | purinergic receptor P2X, ligand-gated ion channel, 4, P2RX4 | 180 |
| 89 | gamma-aminobutyric acid (GABA) receptor, rho 2, GABRR2 | 179 |
| 90 | PDZ and LIM domain 5, PDLIM5 | 177 |
| 91 | plasminogen activator, urokinase, PLAU | 172 |
| 92 | cannabinoid receptor 1 (brain), CNR1 | 172 |
| 93 | chondrolectin, CHODL | 172 |
| 94 | neurexin 2, NRXN2 | 171 |
| 95 | parkinson protein 2, E3 ubiquitin protein ligase (parkin), PARK2 | 169 |
| 96 | calcium channel, voltage-dependent, L type, alpha 1F subunit, CACNA1F | 168 |
| 97 | neuregulin 1, NRG1 | 164 |
| 98 | zinc finger protein 536, ZNF536 | 162 |
| 99 | endothelin 3, EDN3 | 161 |
| 100 | paired box 7, PAX7 | 161 |
| 101 | calcium/calmodulin-dependent protein kinase II beta, CAMK2B | 161 |
| 102 | solute carrier family 30 (zinc transporter), member 3, SLC30A3 | 160 |
| 103 | ciliary neurotrophic factor /// zinc finger protein 91 homolog (mouse) /// ZFP91-CNTF readthrough transcript, CNTF /// ZFP91 /// ZFP91-CNTF | 159 |
| 104 | calcium channel, voltage-dependent, T type, alpha 1I subunit, CACNA1I | 156 |
| 105 | membrane associated guanylate kinase, WW and PDZ domain containing 2, MAGI2 | 155 |
| 106 | sigma non-opioid intracellular receptor 1, SIGMAR1 | 155 |
| 107 | leptin, LEP | 152 |
| 108 | microtubule-associated protein tau, MAPT | 150 |
| 109 | erythropoietin receptor, EPOR | 147 |
| 110 | frizzled homolog 8 (Drosophila), FZD8 | 147 |
| 111 | nuclear mitotic apparatus protein 1, NUMA1 | 147 |
| 112 | ninjurin 2, NINJ2 | 144 |
| 113 | probable transcription factor PML-like /// promyelocytic leukemia, LOC652346 /// PML | 144 |
| 114 | fasciculation and elongation protein zeta 1 (zygin I), FEZ1 | 143 |
| 115 | ribonucleotide reductase M1, RRM1 | 142 |
| 116 | retinoic acid receptor, beta, RARB | 142 |
| 117 | metallothionein 3, MT3 | 142 |
| 118 | vascular endothelial growth factor A, VEGFA | 141 |
| 119 | glycoprotein M6A, GPM6A | 140 |
| 120 | runt-related transcription factor 1, RUNX1 | 136 |
| 121 | cholinergic receptor, nicotinic, delta, CHRND | 135 |
| 122 | testis specific, 10, TSGA10 | 135 |
| 123 | growth hormone secretagogue receptor, GHSR | 135 |
| 124 | guanine nucleotide binding protein (G protein), beta polypeptide 3, GNB3 | 134 |
| 125 | glycine receptor, beta, GLRB | 132 |
| 126 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related), RUNX1T1 | 131 |
| 127 | synaptotagmin V, SYT5 | 131 |
| 128 | bridging integrator 1, BIN1 | 130 |
| 129 | general transcription factor IIi, GTF2I | 128 |
| 130 | mitogen-activated protein kinase kinase 7, MAP2K7 | 127 |
| 131 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, PPARGC1A | 126 |
| 132 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian), ERBB4 | 125 |
| 133 | retinoic acid receptor, alpha, RARA | 123 |
| 134 | baculoviral IAP repeat-containing protein 1-like /// NLR family, apoptosis inhibitory protein, LOC100510692 /// NAIP | 123 |
| 135 | myosin VA (heavy chain 12, myoxin), MYO5A | 122 |
| 136 | heat shock protein 90kDa alpha (cytosolic), class B member 1, HSP90AB1 | 121 |
| 137 | voltage-dependent anion channel 1, VDAC1 | 120 |
| 138 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), PTGS2 | 120 |
| 139 | spectrin, beta, non-erythrocytic 1, SPTBN1 | 120 |
| 140 | tubulin, beta 2A /// tubulin, beta 2B, TUBB2A /// TUBB2B | 119 |
| 141 | misshapen-like kinase 1, MINK1 | 119 |
| 142 | neural cell adhesion molecule 1, NCAM1 | 119 |
| 143 | kelch-like 1 (Drosophila), KLHL1 | 119 |
| 144 | sperm associated antigen 9, SPAG9 | 118 |
| 145 | gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), GNRH1 | 116 |
| 146 | cholinergic receptor, nicotinic, beta 3, CHRNB3 | 115 |
| 147 | neuralized homolog (Drosophila), NEURL | 115 |
| 148 | SRY (sex determining region Y)-box 14, SOX14 | 115 |
| 149 | purinergic receptor P2X, ligand-gated ion channel, 1, P2RX1 | 112 |
| 150 | transcription factor 4, TCF4 | 112 |
| 151 | lysozyme, LYZ | 111 |
| 152 | MYC associated factor X, MAX | 111 |
| 153 | synaptojanin 1, SYNJ1 | 108 |
| 154 | ret proto-oncogene, RET | 108 |
| 155 | cadherin 2, type 1, N-cadherin (neuronal), CDH2 | 108 |
| 156 | AXL receptor tyrosine kinase, AXL | 108 |
| 157 | ataxia telangiectasia mutated, ATM | 107 |
| 158 | parvalbumin, PVALB | 107 |
| 159 | glyceraldehyde-3-phosphate dehydrogenase, GAPDH | 107 |
| 160 | Rap guanine nucleotide exchange factor (GEF) 1, RAPGEF1 | 106 |
| 161 | protein kinase C, gamma, PRKCG | 106 |
| 162 | neurofibromin 2 (merlin), NF2 | 105 |
| 163 | serrate RNA effector molecule homolog (Arabidopsis), SRRT | 105 |
| 164 | syntaxin 3, STX3 | 105 |
| 165 | X-box binding protein 1, XBP1 | 104 |
| 166 | potassium large conductance calcium-activated channel, subfamily M, beta member 2, KCNMB2 | 104 |
| 167 | chemokine (C-X3-C motif) receptor 1, CX3CR1 | 104 |
| 168 | aldehyde dehydrogenase 1 family, member A2, ALDH1A2 | 103 |
| 169 | drebrin 1, DBN1 | 103 |
| 170 | UDP glycosyltransferase 8, UGT8 | 103 |
| 171 | achaete-scute complex homolog 1 (Drosophila), ASCL1 | 103 |
| 172 | POU class 4 homeobox 3, POU4F3 | 102 |
| 173 | neurofibromin 1, NF1 | 102 |
| 174 | steroidogenic acute regulatory protein, STAR | 101 |
| 175 | histamine receptor H3, HRH3 | 101 |
| 176 | nuclear receptor subfamily 2, group F, member 6, NR2F6 | 100 |
| 177 | transforming growth factor, beta 1, TGFB1 | 100 |
| 178 | homeobox D3, HOXD3 | 100 |
| DOWN | Gene Title | Percent Change |
| 81 | 5-hydroxytryptamine (serotonin) receptor 3A, HTR3A | −100 |
| 82 | neuroligin 3, NLGN3 | −101 |
| 83 | aquaporin 1 (Colton blood group), AQP1 | −101 |
| 84 | SH3 and multiple ankyrin repeat domains 2, SHANK2 | −102 |
| 85 | neurochondrin, NCDN | −102 |
| 86 | astrotactin 1, ASTN1 | −102 |
| 87 | mitogen-activated protein kinase 8 interacting protein 2, MAPK8IP2 | −103 |
| 88 | limbic system-associated membrane protein, LSAMP | −103 |
| 89 | calcium binding protein 1, CABP1 | −106 |
| 90 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12), ITGB1 | −107 |
| 91 | discs, large (Drosophila) homolog-associated protein 2, DLGAP2 | −108 |
| 92 | doublecortin, DCX | −108 |
| 93 | colony stimulating factor 3 (granulocyte), CSF3 | −108 |
| 94 | advanced glycosylation end product-specific receptor, AGER | −108 |
| 95 | corticotropin releasing hormone receptor 1, CRHR1 | −109 |
| 96 | neuropeptides B/W receptor 2, NPBWR2 | −109 |
| 97 | even-skipped homeobox 1, EVX1 | −110 |
| 98 | retinoid X receptor, gamma, RXRG | −110 |
| 99 | cytoplasmic polyadenylation element binding protein 3, CPEB3 | −112 |
| 100 | alpha tubulin acetyltransferase 1, ATAT1 | −113 |
| 101 | paralemmin, PALM | −115 |
| 102 | tumor necrosis factor, TNF | −115 |
| 103 | fatty acid binding protein 7, brain, FABP7 | −118 |
| 104 | olfactory marker protein, OMP | −118 |
| 105 | Amphiregulin, AREG | −118 |
| 106 | opioid receptor, kappa 1, OPRK1 | −119 |
| 107 | calbindin 2, CALB2 | −119 |
| 108 | phosphodiesterase 10A, PDE10A | −121 |
| 109 | early growth response 1, EGR1 | −121 |
| 110 | cell cycle exit and neuronal differentiation 1, CEND1 | −123 |
| 111 | 5-hydroxytryptamine (serotonin) receptor 3B, HTR3B | −123 |
| 112 | synaptosomal-associated protein, 23kDa, SNAP23 | −123 |
| 113 | sodium channel, voltage-gated, type XI, alpha subunit, SCN11A | −124 |
| 114 | growth arrest-specific 7, GAS7 | −124 |
| 115 | contactin 1, CNTN1 | −125 |
| 116 | neuroligin 4, X-linked, NLGN4X | −128 |
| 117 | gamma-aminobutyric acid (GABA) A receptor, alpha 1, GABRA1 | −130 |
| 118 | leucine zipper, putative tumor suppressor 1, LZTS1 | −130 |
| 119 | mesenchyme homeobox 2, MEOX2 | −131 |
| 120 | TYRO3 protein tyrosine kinase, TYRO3 | −131 |
| 121 | synaptophysin, SYP | −132 |
| 122 | coiled-coil domain containing 64, CCDC64 | −132 |
| 123 | leucine-rich, glioma inactivated 1, LGI1 | −132 |
| 124 | nerve growth factor receptor, NGFR | −132 |
| 125 | cholinergic receptor, nicotinic, beta 4, CHRNB4 | −135 |
| 126 | 5-hydroxytryptamine (serotonin) receptor 2A, HTR2A | −135 |
| 127 | myocyte enhancer factor 2C, MEF2C | −138 |
| 128 | cholinergic receptor, nicotinic, alpha 4, CHRNA4 | −139 |
| 129 | prodynorphin, PDYN | −142 |
| 130 | discs, large homolog 2 (Drosophila), DLG2 | −142 |
| 131 | neurexin 1, NRXN1 | −144 |
| 132 | secretin, SCT | −148 |
| 133 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, SERPINF1 | −148 |
| 134 | tachykinin receptor 3, TACR3 | −150 |
| 135 | Ras homolog enriched in brain, RHEB | −150 |
| 136 | PARK2 co-regulated, PACRG | −153 |
| 137 | glutamate receptor, ionotropic, kainate 5, GRIK5 | −159 |
| 138 | bone morphogenetic protein 2, BMP2 | −159 |
| 139 | choline O-acetyltransferase, CHAT | −160 |
| 140 | sodium channel, voltage-gated, type I, alpha subunit, SCN1A | −162 |
| 141 | TOX high mobility group box family member 3, TOX3 | −163 |
| 142 | gastric inhibitory polypeptide, GIP | −164 |
| 143 | corticotropin releasing hormone receptor 2, CRHR2 | −165 |
| 144 | kinesin family member 1A, KIF1A | −165 |
| 145 | RAB35, member RAS oncogene family, RAB35 | −166 |
| 146 | protein kinase C, theta, PRKCQ | −167 |
| 147 | cell adhesion molecule with homology to L1CAM (close homolog of L1), CHL1 | −171 |
| 148 | unc-51-like kinase 4 (C. elegans), ULK4 | −172 |
| 149 | wingless-type MMTV integration site family, member 4, WNT4 | −175 |
| 150 | thyroid stimulating hormone receptor, TSHR | −175 |
| 151 | potassium voltage-gated channel, Shal-related subfamily, member 3, KCND3 | −175 |
| 152 | contactin 2 (axonal), CNTN2 | −180 |
| 153 | glutamate receptor, ionotropic, N-methyl D-aspartate 2A, GRIN2A | −180 |
| 154 | fibronectin leucine rich transmembrane protein 1, FLRT1 | −183 |
| 155 | gamma-aminobutyric acid (GABA) A receptor, gamma 3, GABRG3 | −186 |
| 156 | calcium/calmodulin-dependent protein kinase IG, CAMK1G | −187 |
| 157 | interleukin 6 receptor, IL6R | −190 |
| 158 | calsyntenin 3, CLSTN3 | −191 |
| 159 | vesicle-associated membrane protein 1 (synaptobrevin 1), VAMP1 | −193 |
| 160 | promyelocytic leukemia, PML | −196 |
| 161 | ATPase, H+ transporting, lysosomal accessory protein 2, ATP6AP2 | −209 |
| 162 | mitogen-activated protein kinase 8 interacting protein 3, MAPK8IP3 | −209 |
| 163 | estrogen receptor 2 (ER beta), ESR2 | −216 |
| 164 | cytochrome b-245, beta polypeptide, CYBB | −217 |
| 165 | purinergic receptor P2Y, G-protein coupled, 11 /// PPAN-P2RY11 readthrough, P2RY11 /// PPAN-P2RY11 | −219 |
| 166 | sonic hedgehog, SHH | −220 |
| 167 | growth differentiation factor 11, GDF11 | −221 |
| 168 | protein tyrosine phosphatase, receptor type, D, PTPRD | −221 |
| 169 | ELK1, member of ETS oncogene family, ELK1 | −224 |
| 170 | regulating synaptic membrane exocytosis 1, RIMS1 | −225 |
| 171 | hairy/enhancer-of-split related with YRPW motif-like, HEYL | −228 |
| 172 | neurotrophic tyrosine kinase, receptor, type 3, NTRK3 | −230 |
| 173 | potassium voltage-gated channel, Shab-related subfamily, member 2, KCNB2 | −233 |
| 174 | regulator of G-protein signaling 6, RGS6 | −235 |
| 175 | glycine receptor, alpha 3, GLRA3 | −235 |
| 176 | potassium voltage-gated channel, shaker-related subfamily, beta member 1, KCNAB1 | −235 |
| 177 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1, GNAT1 | −242 |
| 178 | proprotein convertase subtilisin/kexin type 2, PCSK2 | −242 |
| 179 | nerve growth factor (beta polypeptide), NGF | −243 |
| 180 | corticotropin releasing hormone, CRH | −243 |
| 181 | laminin, alpha 1, LAMA1 | −245 |
| 182 | cyclic nucleotide gated channel alpha 3, CNGA3 | −249 |
| 183 | glutamate receptor, ionotropic, kainate 1, GRIK1 | −254 |
| 184 | lin-28 homolog A (C. elegans), LIN28A | −259 |
| 185 | empty spiracles homeobox 2, EMX2 | −260 |
| 186 | cyclin-dependent kinase 5, regulatory subunit 1 (p35), CDK5R1 | −260 |
| 187 | agrin, AGRN | −264 |
| 188 | T-box, brain, 1, TBR1 | −272 |
| 189 | stathmin-like 2, STMN2 | −274 |
| 190 | microcephalin 1, MCPH1 | −275 |
| 191 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D), ELAVL4 | −282 |
| 192 | mitogen-activated protein kinase 8 interacting protein 1, MAPK8IP1 | −289 |
| 193 | calcium channel, voltage-dependent, N type, alpha 1B subunit, CACNA1B | −290 |
| 194 | FEZ family zinc finger 2, FEZF2 | −295 |
| 195 | dopamine receptor D4, DRD4 | −296 |
| 196 | zinc finger E-box binding homeobox 1, ZEB1 | −300 |
| 197 | T-cell leukemia homeobox 1, TLX1 | −311 |
| 198 | sterile alpha motif domain containing 4A, SAMD4A | −315 |
| 199 | opioid binding protein/cell adhesion molecule-like, OPCML | −333 |
| 200 | fibroblast growth factor receptor 2, FGFR2 | −337 |
| 201 | SRY (sex determining region Y)-box 1, SOX1 | −337 |
| 202 | neurogenin 1, NEUROG1 | −345 |
| 203 | PTK2B protein tyrosine kinase 2 beta, PTK2B | −348 |
| 204 | somatostatin receptor 5, SSTR5 | −353 |
| 205 | myelin basic protein, MBP | −361 |
| 206 | EPH receptor A7, EPHA7 | −365 |
| 207 | G protein-coupled receptor 173, GPR173 | −373 |
| 208 | S100 calcium binding protein A5, S100A5 | −374 |
| 209 | acyl-CoA synthetase long-chain family member 6, ACSL6 | −384 |
| 210 | family with sequence similarity 107, member A, FAM107A | −407 |
| 211 | Kv channel interacting protein 1, KCNIP1 | −413 |
| 212 | Fas apoptotic inhibitory molecule 2, FAIM2 | −416 |
| 213 | bradykinin receptor B1, BDKRB1 | −426 |
| 214 | discs, large homolog 4 (Drosophila), DLG4 | −452 |
| 215 | adenylate cyclase 10 (soluble), ADCY10 | −460 |
| 216 | cyclin-dependent kinase 5, regulatory subunit 2 (p39), CDK5R2 | −481 |
| 217 | EPH receptor A3, EPHA3 | −485 |
| 218 | phosphodiesterase 1A, calmodulin-dependent, PDE1A | −485 |
| 219 | chemokine (C-X-C motif) receptor 4, CXCR4 | −496 |
| 220 | membrane metallo-endopeptidase, MME | −540 |
| 221 | paired-like homeodomain 3, PITX3 | −541 |
| 222 | notch 3, NOTCH3 | −547 |
| 223 | discs, large (Drosophila) homolog-associated protein 1, DLGAP1 | −547 |
| 224 | slit homolog 1 (Drosophila), SLIT1 | −553 |
| 225 | bassoon (presynaptic cytomatrix protein), BSN | −563 |
| 226 | cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila), CELSR1 | −647 |
| 227 | calcium channel, voltage-dependent, beta 4 subunit, CACNB4 | −672 |
| 228 | necdin homolog (mouse), NDN | −729 |
| 229 | endothelin receptor type B, EDNRB | −768 |
| 230 | cholinergic receptor, muscarinic 2, CHRM2 | −1049 |